Cargando…

An Updated Analysis of the Impact of HPV Vaccination Based on Long-term Effectiveness in the Netherlands

INTRODUCTION: Vaccination against human papillomavirus (HPV) is considered the most effective strategy to protect women from cervical cancer. Three HPV vaccines are currently licensed in Europe and, although they are generally supported by favorable health economic outcomes, current models fall shor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luttjeboer, Jos, Simons, Joost, Westra, Tjalke, Wilschut, Jan, Boersma, Cornelis, Postma, Maarten, van der Schans, Jurjen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505117/ https://www.ncbi.nlm.nih.gov/pubmed/37563438 http://dx.doi.org/10.1007/s40121-023-00851-9

Ejemplares similares

Cost-effectiveness of a male catch-up human papillomavirus vaccination program in the Netherlands
por: Simons, Joost J.M., et al.
Publicado: (2022)

Vaccination process of immunocompromised patients in the Netherlands: Current challenges and potential solutions
por: de Laat, Cindy R., et al.
Publicado: (2023)

Exploratory Analysis of the Economically Justifiable Price of a Hypothetical RSV Vaccine for Older Adults in the Netherlands and the United Kingdom
por: Zeevat, F, et al.
Publicado: (2021)

Meningococcal Serogroup A, C, W(135) and Y Conjugated Vaccine: A Cost-Effectiveness Analysis in the Netherlands
por: Hepkema, Hiltsje, et al.
Publicado: (2013)

Rotavirus Vaccination of Infants Delayed and Limited within the National Immunization Programme in the Netherlands: An Opportunity Lost
por: Zeevat, Florian, et al.
Publicado: (2021)

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands
por: Westra, Tjalke A, et al.
Publicado: (2013)

Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands
por: Hagendijk, Marije E., et al.
Publicado: (2021)

Cost-Effectiveness of Adolescent Pertussis Vaccination for The Netherlands: Using an Individual-Based Dynamic Model
por: de Vries, Robin, et al.
Publicado: (2010)

Investing in the Prevention of Communicable Disease Outbreaks: Fiscal Health Modelling—The Tool of Choice for Assessing Public Finance Sustainability
por: van der Schans, Simon, et al.
Publicado: (2023)

Reconstructing the Effectiveness of Policy Measures to Avoid Next-Wave COVID-19 Infections and Deaths Using a Dynamic Simulation Model: Implications for Health Technology Assessment
por: Hagens, Arnold, et al.
Publicado: (2022)

Inequalities in Rotavirus Vaccine Uptake in Ethiopia: A Decomposition Analysis
por: Wondimu, Abrham, et al.
Publicado: (2020)

Translation and performance of the Finnish Diabetes Risk Score for detecting undiagnosed diabetes and dysglycaemia in the Indonesian population
por: Rokhman, M. Rifqi, et al.
Publicado: (2022)

Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands
por: Eijsink, Job F. H., et al.
Publicado: (2020)

Non-restrictive open vial policy combined with the home visit vaccinations for improving BCG coverage in a high-incidence outreach region: A model-based cost-effectiveness analysis for Indonesia
por: Machlaurin, Afifah, et al.
Publicado: (2023)

Pneumococcal Vaccination for Children in Asian Countries: A Systematic Review of Economic Evaluation Studies
por: Zakiyah, Neily, et al.
Publicado: (2020)

Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model
por: Rozenbaum, Mark H, et al.
Publicado: (2011)

Health Economics of Vaccines: From Current Practice to Future Perspectives
por: Boersma, Cornelis, et al.
Publicado: (2021)

An update of “Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model”
por: Tu, Hong Anh T, et al.
Publicado: (2013)

Psychometric properties of kidney disease quality of life-36 (KDQOL-36) in dialysis patients in Indonesia
por: Rokhman, M. Rifqi, et al.
Publicado: (2022)

Cost-Effectiveness of Extended-Release Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Sub-Optimally Treated with Immediate Release Methylphenidate
por: van der Schans, Jurjen, et al.
Publicado: (2015)

Equity in human papilloma virus vaccination uptake?: sexual behaviour, knowledge and demographics in a cross-sectional study in (un)vaccinated girls in the Netherlands
por: Mollers, Madelief, et al.
Publicado: (2014)

COVID-19 Vaccination Scenarios: A Cost-Effectiveness Analysis for Turkey
por: Hagens, Arnold, et al.
Publicado: (2021)

Monitoring physical impact and recovery of pancreatic cancer treatment using consumer wearable health data: A case report
por: van der Schans, Cees P, et al.
Publicado: (2023)

P53 The Early Lessons of COVID-19: The Need for a Broader Health-Economic Perspective
por: Schöttler, M, et al.
Publicado: (2022)

A Model Based Cost-Effectiveness Analysis of Routine Genotyping for CYP2D6 among Older, Depressed Inpatients Starting Nortriptyline Pharmacotherapy
por: Berm, Elizabeth J. J., et al.
Publicado: (2016)

P68 Investing in the Prevention of Infectious Disease Outbreaks: Fiscal Health Modelling for Assessing the Public Investment Case
por: Schöttler, M, et al.
Publicado: (2022)

Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines
por: de Boer, Pieter T., et al.
Publicado: (2018)

Updates on HPV Vaccination
por: Illah, Ojone, et al.
Publicado: (2023)

Assessment of the Broader Economic Consequences of HPV Prevention from a Government-Perspective: A Fiscal Analytic Approach
por: Setiawan, Didik, et al.
Publicado: (2016)

The Cost-Effectiveness of Hepatitis C Virus Screening Strategies among Recently Arrived Migrants in the Netherlands
por: Al Khayat, Mohamed N.M.T., et al.
Publicado: (2020)

Reply to Anglemyer et al
por: Zeevat, Florian, et al.
Publicado: (2021)

Factors associated with the uptake of newly introduced childhood vaccinations in Ethiopia: the cases of rotavirus and pneumococcal conjugate vaccines
por: Wondimu, Abrham, et al.
Publicado: (2019)

PRS27 Incorporating Heterogeneity in Risk for Infection and Disease in Cost-Effectiveness of Preventative Strategies in Older Adults
por: Zeevat, F., et al.
Publicado: (2020)

Cost-effectiveness of non-communicable disease prevention in Southeast Asia: a scoping review
por: Nguyen, Thi-Phuong-Lan, et al.
Publicado: (2023)

A longitudinal study on determinants of HPV vaccination uptake in parents/guardians from different ethnic backgrounds in Amsterdam, the Netherlands
por: Alberts, Catharina J., et al.
Publicado: (2017)

Determinants of HPV-vaccination uptake and subgroups with a lower uptake in the Netherlands
por: de Munter, A. C., et al.
Publicado: (2021)

Cost-Effectiveness of Treatments in Children With Attention-Deficit/Hyperactivity Disorder: A Continuous-Time Markov Modeling Approach
por: Freriks, Roel D., et al.
Publicado: (2019)

Comparatively low attendance during Human Papillomavirus catch-up vaccination among teenage girls in the Netherlands: Insights from a behavioral survey among parents
por: Gefenaite, Giedre, et al.
Publicado: (2012)

Country score tool to assess readiness and guide evidence generation of immunization programs in aging adults in Europe
por: Pham, Thi Hao, et al.
Publicado: (2023)

Concordance assessment of self-reported medication use in the Netherlands three-generation Lifelines Cohort study with the pharmacy database iaDB.nl: The PharmLines initiative
por: Sediq, Rahmat, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d1ci4d8no13iics4o5irmvk7au